News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Seventh Sense Biosystems Inc. Receives $3.28 Million Grand Challenges Point-of-Care Diagnostics Grant to Expand Touch Activated Phlebotomy™ Technology Platform



12/16/2011 7:24:19 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seventh Sense Biosystems, Inc., a company developing novel blood sampling technology for decentralized diagnostic testing, announced today that it has been awarded a $3.28 million grant from the Bill & Melinda Gates Foundation. The grant is part of the Grand Challenges in Global Health initiative to seek out innovative ideas for diagnostics in the developing world. Seventh Sense’s proprietary Touch Activated Phlebotomy™ (TAP) technology platform is one of more than twenty Grand Challenges point-of-care diagnostics grants announced today. This Grand Challenges program aims to create technologies and components that can enhance assessment of conditions and pathogens at the point-of-care in a variety of settings.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES